What does CUSIP 45826J105 represent in this 13F holders report?

CUSIP 45826J105 is the security identifier for NTLA - Intellia Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held NTLA - Intellia Therapeutics, Inc. - Common Stock in Q2 2020?

160 institutional investors reported NTLA - Intellia Therapeutics, Inc. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

Intellia Therapeutics, Inc. - Common Stock (NTLA)

CUSIP: 45826J105

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 116,932,531
Total 13F shares: 53,928,267
Share change: +7,428,540
Total reported value: $1,127,243,500
Put/Call ratio: 40%
Price per share: $21.02
Number of holders: 160
Value change: +$160,801,520
Number of buys: 98
Number of sells: 47

Quarterly Holders Quick Answers

What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 45826J105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NTLA - Intellia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARK Investment Management LLC	13F	Company	8.8%	10,239,286	$125,226,000	—	31 Mar 2020	13F
Amova Asset Management Americas, Inc.	13F	Company	6.1%	7,091,263	$86,726,000	—	31 Mar 2020	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	6.1%	7,091,263	$86,726,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	3.2%	3,792,298	$46,379,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	3%	3,488,249	$42,661,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	1.5%	1,724,683	$21,093,000	—	31 Mar 2020	13F
Atlas Venture Associates IX, LLC	13F	Company	1.4%	1,615,321	$19,756,000	—	31 Mar 2020	13F
Chevy Chase Trust Holdings, LLC	13F	Company	1.2%	1,384,812	$16,935,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.88%	1,024,504	$12,530,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.77%	897,037	$10,971,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	0.71%	831,744	$10,172,000	—	31 Mar 2020	13F
Temasek Holdings (Private) Ltd	13F	Company	0.68%	790,527	$9,668,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.55%	648,852	$7,935,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.51%	591,041	$7,228,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.44%	510,891	$6,249,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.25%	296,715	$3,629,000	—	31 Mar 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.22%	262,100	$3,205,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.22%	256,917	$3,142,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.21%	246,878	$3,020,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.19%	223,622	$2,735,000	—	31 Mar 2020	13F
Ikarian Capital, LLC	13F	Company	0.16%	184,989	$2,262,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.15%	172,945	$2,115,000	—	31 Mar 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.14%	159,194	$1,947,000	—	31 Mar 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	0.11%	128,538	$1,572,000	—	31 Mar 2020	13F
ROYAL BANK OF CANADA	13F	Company	0.1%	119,027	$1,455,000	—	31 Mar 2020	13F
Of The University Of California Regents	13F	Individual	0.1%	111,440	$1,363,000	—	31 Mar 2020	13F
PDT Partners, LLC	13F	Company	0.09%	103,100	$1,261,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.08%	92,956	$1,137,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	86,880	$1,062,000	—	31 Mar 2020	13F
Elmwood Wealth Management, Inc.	13F	Company	0.04%	49,138	$1,036,320	—	31 Mar 2020	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.07%	83,737	$1,024,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0.07%	81,669	$999,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.07%	80,727	$988,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.07%	78,800	$964,000	—	31 Mar 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.07%	77,438	$947,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.06%	75,632	$925,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.06%	73,394	$897,000	—	31 Mar 2020	13F
Allianz Asset Management GmbH	13F	Company	0.06%	68,595	$839,000	—	31 Mar 2020	13F
SHELTON CAPITAL MANAGEMENT	13F	Company	0.06%	68,300	$835,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.06%	65,500	$801,000	—	31 Mar 2020	13F
Creative Planning	13F	Company	0.05%	63,561	$777,000	—	31 Mar 2020	13F
Neuberger Berman Group LLC	13F	Company	0.05%	60,812	$744,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0.05%	60,455	$739,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.05%	59,700	$730,000	—	31 Mar 2020	13F
Granahan Investment Management, LLC	13F	Company	0.05%	59,342	$726,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.05%	58,392	$714,000	—	31 Mar 2020	13F
Tekla Capital Management LLC	13F	Company	0.05%	55,050	$673,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.05%	53,600	$656,000	—	31 Mar 2020	13F
WS MANAGEMENT LLLP	13F	Company	0.04%	49,230	$602,000	—	31 Mar 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.04%	48,793	$596,739	—	31 Mar 2020	13F

Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q2 2020

As of 30 Jun 2020, Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by 160 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,928,267 shares. The largest 10 holders included ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Atlas Venture Associates IX, LLC, FMR LLC, Chevy Chase Trust Holdings, Inc., and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 160 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

133

Q2 2020 holders

160

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.